Davies, Melanie J.

Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): a randomized clinical trial

Davies, M. J., Bain, S. C., Atkin, S. L., Rossing, P., Scott, D., Shamkhalova, M. S., Bosch-Traberg, H., Syrén, A., & Umpierrez, G. E. (2016) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 235

Association between adherence to pharmacotherapy and outcomes in type 2 diabetes: a meta-analysis

Khunti, K., Seidu, S., Kunutsor, S., & Davies, M. (2017) · Diabetes Care

Medication Adherence and ComplianceDiabetes Treatment and Management

Cited by 231

A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans

Sargeant, J. A., Henson, J., King, J. A., Yates, T., Khunti, K., & Davies, M. J. (2019) · Endocrinology and Metabolism

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 231

Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis

Morris, D. H., Khunti, K., Achana, F., Srinivasan, B., Gray, L. J., Davies, M. J., & Webb, D. (2013) · Diabetologia

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 229

Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

Borlaug, B. A., Kitzman, D. W., Davies, M. J., Rasmussen, S., Barros, E., Butler, J., Einfeldt, M. N., Hovingh, G. K., Møller, D. V., Petrie, M. C., et al. (2023) · Nature Medicine

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 215

A systematic review and meta-analysis to compare the prevalence of depression between people with and without Type 1 and Type 2 diabetes

Farooqi, A., Gillies, C., Sathanapally, H., Abner, S., Seidu, S., Davies, M. J., Polonsky, W. H., & Khunti, K. (2022) · Primary Care Diabetes

Diabetes Management and EducationMental Health Treatment and Access

Cited by 204

Gastrointestinal tolerability of once‐weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss

Wharton, S., Calanna, S., Davies, M., Dicker, D., Goldman, B., Lingvay, I., Mosenzon, O., Rubino, D. M., Thomsen, M., Wadden, T. A., et al. (2022) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 200

Accelerometer-assessed Physical Activity in Epidemiology: Are Monitors Equivalent?

ROWLANDS, A. V., MIRKES, E. M., YATES, T., CLEMES, S., DAVIES, M., KHUNTI, K., & EDWARDSON, C. L. (2018) · Medicine & Science in Sports & Exercise

Physical Activity and HealthContext-Aware Activity Recognition Systems

Cited by 187

The association between depression and health‐related quality of life in people with type 2 diabetes: a systematic literature review

Ali, S., Stone, M., Skinner, T. C., Robertson, N., Davies, M., & Khunti, K. (2010) · Diabetes/Metabolism Research and Reviews

Diabetes Management and EducationCancer survivorship and care

Cited by 186

The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis

Potts, J. E., Gray, L. J., Brady, E. M., Khunti, K., Davies, M. J., & Bodicoat, D. H. (2015) · PLOS ONE

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 163

The role of physical activity in the management of impaired glucose tolerance: a systematic review

Yates, T., Khunti, K., Bull, F., Gorely, T., & Davies, M. J. (2007) · Diabetologia

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 161

Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: Systematic review and mixed treatment comparison meta-analysis

Dunkley, A. J., Charles, K., Gray, L. J., Camosso‐Stefinovic, J., Davies, M. J., & Khunti, K. (2012) · Diabetes Obesity and Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 151

Self-Reported Sitting Time and Markers of Inflammation, Insulin Resistance, and Adiposity

Yates, T., Khunti, K., Wilmot, E. G., Brady, E., Webb, D., Srinivasan, B., Henson, J., Talbot, D., & Davies, M. J. (2012) · American Journal of Preventive Medicine

Physical Activity and HealthAdipokines, Inflammation, and Metabolic Diseases

Cited by 147

Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

Davies, M. J., Bajaj, H. S., Broholm, C., Eliasen, A., Garvey, W. T., le Roux, C. W., Lingvay, I., Lyndgaard, C. B., Rosenstock, J., & Pedersen, S. D. (2025) · New England Journal of Medicine

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 143

Initiate Insulin by Aggressive Titration and Education (INITIATE)

Yki-Järvinen, H., Juurinen, L., Alvarsson, M., Bystedt, T., Caldwell, I., Davies, M., Lahdenperä, S., Nijpels, G., & Vähätalo, M. (2007) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 139

Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management

Sinha, R., Papamargaritis, D., Sargeant, J. A., & Davies, M. J. (2023) · Journal of Obesity & Metabolic Syndrome

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 138

Placebo‐controlled, randomized trial of the addition of once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes ( AWARD ‐9)

Pozzilli, P., Norwood, P., Jódar, E., Davies, M. J., Ivanyi, T., Jiang, H., Woodward, D. B., & Milicevic, Z. (2017) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 137

Early weight loss with liraglutide 3.0 mg predicts 1-year weight loss and is associated with improvements in clinical markers

Fujioka, K., O'Neil, P. M., Davies, M., Greenway, F., C.W. Lau, D., Claudius, B., Skjøth, T. V., Bjørn Jensen, C., & P.H. Wilding, J. (2016) · Obesity

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 131

Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses

Kosiborod, M. N., Bhatta, M., Davies, M., Deanfield, J. E., Garvey, W. T., Khalid, U., Kushner, R., Rubino, D. M., Zeuthen, N., & Verma, S. (2023) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 127

Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus

Ibrahim, M., Davies, M. J., Ahmad, E., Annabi, F. A., Eckel, R. H., Ba-Essa, E. M., El Sayed, N. A., Hess Fischl, A., Houeiss, P., Iraqi, H., et al. (2020) · BMJ Open Diabetes Research & Care

Dietary Effects on HealthDiabetes Management and Research

Cited by 124

A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial

Davies, M. J., Gray, L. J., Troughton, J., Gray, A., Tuomilehto, J., Farooqi, A., Khunti, K., & Yates, T. (2016) · Preventive Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Education

Cited by 123

Clinical inertia—time to reappraise the terminology?

Khunti, K., & Davies, M. J. (2017) · Primary Care Diabetes

Diabetes Treatment and ManagementClinical practice guidelines implementation

Cited by 121

Defining Obesity Cut-Off Points for Migrant South Asians

Gray, L. J., Yates, T., Davies, M. J., Brady, E., Webb, D. R., Sattar, N., & Khunti, K. (2011) · PLoS ONE

Diabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet

Cited by 120

Do sulphonylureas still have a place in clinical practice?

Khunti, K., Chatterjee, S., Gerstein, H. C., Zoungas, S., & Davies, M. J. (2018) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 116